First Horizon Advisors’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-649
Closed -$17.6K 2333
2023
Q4
$17.6K Hold
649
﹤0.01% 1379
2023
Q3
$19.2K Hold
649
﹤0.01% 1267
2023
Q2
$23.2K Buy
649
+312
+93% +$8.96K ﹤0.01% 1207
2023
Q1
$7.9K Sell
337
-6
-2% -$171 ﹤0.01% 1643
2022
Q4
$9.33K Sell
343
-23
-6% -$1.05K ﹤0.01% 1595
2022
Q3
$19K Buy
366
+150
+69% +$7.7K ﹤0.01% 1252
2022
Q2
$8K Buy
216
+209
+2,986% +$10.4K ﹤0.01% 1664
2022
Q1
$0 Sell
7
-356
-98% -$24.4K ﹤0.01% 1934
2021
Q4
$36K Hold
363
﹤0.01% 1060
2021
Q3
$44K Hold
363
﹤0.01% 958
2021
Q2
$44K Sell
363
-12
-3% -$1.61K ﹤0.01% 837
2021
Q1
$56K Sell
375
-92
-20% -$13.9K ﹤0.01% 695
2020
Q4
$59K Buy
467
+13
+3% +$1.5K ﹤0.01% 550
2020
Q3
$50K Buy
454
+25
+6% +$2.29K ﹤0.01% 537
2020
Q2
$34K Hold
429
﹤0.01% 624
2020
Q1
$28K Buy
429
+279
+186% +$21.4K ﹤0.01% 617
2019
Q4
$11K Hold
150
﹤0.01% 1036
2019
Q3
$9K Hold
150
﹤0.01% 1097
2019
Q2
$12K Buy
+150
New +$11.5K ﹤0.01% 1027

Other funds holding GH

First Horizon Advisors's GH Position: Q1 2024 in Review

First Horizon Advisors sold out of Guardant Health (GH) in Q1 2024, closing a stake of 649 shares — an estimated $17.6K sold.

First Horizon Advisors first reported a position in GH in Q2 2019 and held it in 19 quarters. The position peaked at $59K in Q4 2020. 258 funds tracked by Wall St. Rank hold GH as of Q1 2024.

  • First Horizon Advisors reported no remaining Guardant Health position as of Q1 2024 after selling out during the quarter.
  • First Horizon Advisors sold 649 Guardant Health shares in Q1 2024, an estimated $17.6K.
  • First Horizon Advisors first reported a position in Guardant Health in Q2 2019 and held it in 19 quarters.
  • First Horizon Advisors's Guardant Health position peaked at $59K in Q4 2020.
  • 258 funds tracked by Wall St. Rank held Guardant Health as of Q1 2024.

Based on First Horizon Advisors's 13F filing for Q1 2024, filed 26 Apr 2024.